Tscan therapeutics named top place to work by the boston globe for two consecutive years

Waltham, mass., nov. 30, 2023 (globe newswire) -- tscan therapeutics, inc. (nasdaq: tcrx), a clinical-stage biopharmaceutical company focused on the development of t cell receptor (tcr)-engineered t cell therapies (tcr-t) for the treatment of patients with cancer, today announced it has been named one of the top places to work in massachusetts in the 16th annual employee-based survey project from the boston globe. the top places to work 2023 was published online at globe.com/topplaces and will appear in the globe magazine on sunday, december 3, 2023.
TCRX Ratings Summary
TCRX Quant Ranking